Vector Space Biosciences and Advacam Partner to Map Radiation in Space and Develop AI Models for the New Space Industry Economy

VSB (SBIO) and Advacam will partner to design and develop CubeSats along with measuring radiation and launching payloads for biotechnology

Advacam and Vector Space Biosciences (crypto: $SBIO) have signed a Letter of Intent (LOI) to collaborate on satellite payload design and development for CubeSats. Together, they aim to measure radiation and launch payloads for biotechnology, pharmaceutical companies, and space radiation hardening of medical device chipsets.

This collaboration will involve launching Advacam's Timepix2 radiation detectors on VSB's CubeSats to measure Galactic Cosmic Rays (GCRs) and other forms of radiation in Low Earth Orbit (LEO). The data collected will be used to assess the impact of radiation on biological payloads, such as Waterbears (Tardigrades), and to optimize the hardening of AI semiconductors and other chipsets for space applications.

VSB's first launch, scheduled for Q1/Q2 2025 (or sooner), will include approximately 50 Waterbears and the Timepix2 detector. The company aims to achieve 2-3+ launches per week, with each launch carrying multiple payloads and up to 10 CubeSats. VSB and Advacam partners and customers will have the opportunity to sponsor each CubeSat launch.

Each payload generates valuable data that is modeled using an ensemble of proprietary and best-in-class targeted language models. This data can be used to identify hidden relationships and generate new discoveries in biotechnology, pharmaceuticals, and space technology.

Companies like Merck and Bristol Myers are leading the way in using data from space to develop more effective or new kinds of drug compounds.

Advacam and VSB will collaborate on points described in the LOI, such as:

* Enabling revenue-sharing with customers, including biotechnology, pharmaceutical and AI semiconductor customers to take snapshots and measure space radiation including Galactic Cosmic Rays (GCRs) and high-charge, high-energy particles (HZEs) via the Advacam MiniPix Sprinter (Timepix2).

* Launching the devices into Low Earth Orbit (LEO), following the same orbit as the ISS to generate reports for precision, accuracy, optimizations.

* Constructing historical flight heritage logs for Advacam.

* Vacuum case testing in LEO

* Providing joint marketing and PR along with customer referrals.

* Collaborating on detailed AI modeling and analysis of GCRs and HZE particles along with data snapshots and timestamps.

* Advacam and VSB will jointly work together to provide extended and advanced AI services in the analysis of datasets associated with VSB customer CubeSat payloads based on VSB’s work at Lawrence Berkeley National Laboratory and VSB Scientific Advisory Board (SAB).

About Vector Space Biosciences

VSB develops AI models with data from the space industry, enabling biotechnology, pharmaceutical, and AI semiconductor customers to launch payloads via CubeSats, to develop new drug compounds and radiation-harden AI semiconductors. The data from biological payloads and AI modeling (language modeling) can be used to develop new forms of precision medicine related to human aging and cancer or provide insights into radiation’s effect on AI semiconductors used in data centers being built in space today. Our primary goal connects to understanding how to develop countermeasures against stressors on the human body during spaceflight, like microgravity and radiation, resulting in new forms of precision medicine for all mankind. VSB maintains the crypto: $SBIO, a utility token based in Dubai and parent company to VXV and other spinoffs in the space and precision medicine industry. More information can be found here: https://vectorspacebio.science/technology

Contacts

Christopher Bartlett

chris@thinkgem.com

203-494-4806

support@vectorspacebio.science | Reddit | Telegram | Discord | twitter